Pancreatic cancer cachexia: a review of mechanisms and therapeutics. - Wikidata - wikimedia - TriplyDB

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

http://www.wikidata.org/entity/Q34660312

about

Nutrition in Patients with Gastric Cancer: An Update Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer Early Parenteral Nutrition in Patients with Biliopancreatic Mass Lesions, a Prospective, Randomized Intervention Trial Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.Cancer tolerance, resistance, pathogenicity and virulence: deconstructing the disease state.Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.Understanding tumor anabolism and patient catabolism in cancer-associated cachexia Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.IL-4 mRNA Is Downregulated in the Liver of Pancreatic Cancer Patients Suffering from Cachexia.The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer.Plasma inflammatory cytokines and survival of pancreatic cancer patients.Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy.Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.Risk factors for pancreatic cancer: underlying mechanisms and potential targets

P2860

Q26741105-9818B042-1FC8-4E0E-83A0-5053F70EE4AF Q33755930-6824C3E4-FEFD-4E52-A1CE-6E74BD41D794 Q33887434-2D3E0B5F-DFCC-4D17-B19D-4939A746522E Q34215987-EA8DDDF3-55FA-4F91-9FD8-324D1F859728 Q34669261-AEB321B2-C1A5-4A29-B2FE-9E837A41AD3D Q34860695-34A09D59-55AA-4F50-8239-CFDF6C88222B Q35690582-E2A3D644-3B8C-4066-9A18-A6DDE20A98EB Q35970523-10A47140-FD8A-4CB0-BA7C-AF7BEBDA8480 Q36001882-3F36BA43-A16D-4B9E-B9D8-2E008441998B Q36197291-07AB30C3-A888-4218-B2EA-FF145727968E Q38807599-D33CB3C8-E0F0-44AA-A94E-A27550C65311 Q38888152-411B1108-A8D7-4530-8B87-3EE51FD04F0D Q38909404-76A1BAA6-EF76-476B-848F-10159054864A Q39339489-65873E82-9100-4F30-AF44-22A8000D76B7 Q39726480-E02776EE-2310-477E-8018-9AD435FC0B4F Q51038131-92623697-60BA-4FE1-826C-57205DFD7FBA Q51266754-F21BA09E-6CE1-4F70-B049-C1B67CDD2BED Q52565516-85002FB5-03A4-41A1-BDFD-27BCD76D9614 Q55259105-BB7C6A7C-B542-45AE-A974-E85FC3CA6288 Q55513822-0BF05810-CF24-49B5-B8C4-2DCE278EA573 Q58563303-BF449E0C-A67D-4A5A-A2DF-4A5204928CB5

P2860

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

http://www.wikidata.org/entity/Q34660312

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@ast

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@en

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@nl

type

label

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@ast

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@en

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@nl

prefLabel

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@ast

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@en

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@nl

P1433

Q34660312-1A9F1935-0970-4DAD-855E-05D31CD302BB

P1476

Q34660312-EE0CC6D5-F4A3-4F71-AC7F-15FBD62A3D42

P2093

Q34660312-40702A66-DF2F-4907-917A-1A3CFEB2E672

Q34660312-9179CBC7-44F0-4C87-A2CD-7C5AC7320405

Q34660312-A9676608-A162-4BF8-BDC3-BDC42EE24BD7

Q34660312-C974863A-983E-4808-95C8-FB1864308735

Q34660312-DFF59FC4-39E3-4B8E-819F-AC8FD16ABA4F

Q34660312-E8BD0FFF-53C2-4022-B6DA-837E8E68F728

Q34660312-EA465661-9BB1-40DD-B84A-5495AE2F23FB

Q34660312-FA003838-AB11-4127-8F11-F616B4B8BF25

P2860

Q34660312-02857F66-34E9-4580-8D8C-498C9AC45E5D

Q34660312-03F042EE-7B51-4266-8A67-27BA5A72C67F

Q34660312-06741DA2-0259-42A2-BC3F-BA8A577BEA25

Q34660312-0B40A9F8-918A-47CA-A6B3-3F641A654517

Q34660312-11B5EF6A-6E00-4597-868C-29C287BC6881

Q34660312-124A3D65-CAC7-4307-9351-E8BAA79A259E

Q34660312-143A337A-07C0-4D44-8190-5AE1D3EF24B8

Q34660312-15096336-D138-45B2-9A71-50343793A55D

Q34660312-15851ACE-C8C1-41A7-A80C-C449DBFF4300

Q34660312-1AEC1493-7544-443B-AF47-C80E80329CB0

P304

Q34660312-903D12DC-6F4C-4B9D-B8E6-02C8924B3B79

P31

Q34660312-7EBFF396-1004-42EC-8773-B96FD3F0A9D6

P356

Q34660312-AA17A22A-2D87-4DC2-BAC9-54C03504E070

P478

Q34660312-37003A0B-593D-4833-A5B3-5DE9AD5DBE2F

P577

Q34660312-DA221D5B-1C31-4C70-BFA3-527265223E62

P5875

Q34660312-BBCCA4A2-737D-48A7-B9FA-29D59CA7619B

P698

Q34660312-1C143C08-A61E-4350-BA22-6CCFD80111C9

P932

Q34660312-AACCE010-C9FD-4DBF-BCA7-EBFB68725A43

P356

FPHYS.2014.00088

P1433

Frontiers in Physiology

P1476

Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

@en

P2093

Andrew E Hendifar

http://www.w3.org/2001/XMLSchema#string

Carlyn R Tan

http://www.w3.org/2001/XMLSchema#string

Laith H Jamil

http://www.w3.org/2001/XMLSchema#string

Nicholas Nissen

http://www.w3.org/2001/XMLSchema#string

Patrick M Yaffee

http://www.w3.org/2001/XMLSchema#string

Richard Tuli

http://www.w3.org/2001/XMLSchema#string

Simon K Lo

http://www.w3.org/2001/XMLSchema#string

Stephen J Pandol

http://www.w3.org/2001/XMLSchema#string

P2860

Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

Dermcidin: a novel human antibiotic peptide secreted by sweat glands

Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cells

Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation

The cachectic mediator proteolysis inducing factor activates NF-kappaB and STAT3 in human Kupffer cells and monocytes

Characterization of a cancer cachectic factor

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)

Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function

P304

88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2014.00088

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260761476

http://www.w3.org/2001/XMLSchema#string

P698

24624094

http://www.w3.org/2001/XMLSchema#string

P932

3939686

http://www.w3.org/2001/XMLSchema#string